Cardiovascular events by different target hemoglobin levels in ESA-hyporesponsive hemodialysis patients: a multicenter, open-label, randomized controlled study

Cardiovascular events by different target hemoglobin levels in ESA-hyporesponsive hemodialysis patients: a multicenter, open-label, randomized controlled study

Abstract Background The incidence of cardiovascular (CV) events is high in hemodialysis (HD) patients and is associated with hyporesponsiveness to erythropoiesis-stimulating agents (ESAs). However, there are no recommended target hemoglobin ranges for ESA-hyporesponsive patients. Methods We randomly...

Full description

Bibliographic Details
Main Authors: Kosaku Nitta, Takahiro Kuragano, Nobuhiko Joki, Kazuhiko Tsuruya, Hirokazu Honda, Takayuki Hamano, Hideki Fujii, Yukari Uemura, Ken Tsuchiya, the PARAMOUNT-HD Study Investigators
Format: Article
Language:English
Published: BMC 2022-12-01
Series:Renal Replacement Therapy
Subjects:
ESA hyporesponsiveness
Cardiovascular events
Hemodialysis
Target hemoglobin
Online Access:https://doi.org/10.1186/s41100-022-00450-3

Internet

https://doi.org/10.1186/s41100-022-00450-3

Similar Items